Protective activity of the lipid A analogue GLA-60 against murine cytomegalovirus infection in immunodeficient mice — Satoru Ikeda (1993) | RDL Network
Protective activity of the lipid A analogue GLA-60 against murine cytomegalovirus infection in immunodeficient mice
Article 1993 en
Authors
SI
Satoru Ikeda
JN
Johan Neyts
MM
Motohiro Matsuura
Abstract
1 min read
The immunomodulating and murine cytomegalovirus (MCMV)-inhibiting effects of the synthetic lipid A subunit analogue GLA-60 were investigated in different strains of immunodeficient mice. Peritoneal natural killer (NK) cells obtained from nude (nu/nu) C57BL/6 mice or normal NMRI mice, which had been treated intraperitoneally with 10 micrograms of GLA-60 1 day earlier, exhibited a greater cytolytic activity than those from untreated mice. GLA-60 also stimulated NK cell activity in SCID (severe combined immune deficiency) mice (which are T and B cell-defective), but not in NK cell-defective beige (C57BL/6 bg/bg) mice. GLA-60 also enhanced the phagocytic activity of peritoneal macrophages in beige, nude and NMRI mice, but not in SCID mice. GLA-60, when administered as a single 150 micrograms dose 1 day before infection, completely protected beige mice against MCMV-associated mortality. It also caused a significant increase in the life-span of MCMV-infected nude and SCID mice.
Thomas Delale, André Paquin, Carine Asselin‐Paturel, Marc Dalod, Géraldine Brizard, Elizabeth E. M. Bates, Philippe Kastner, Susan Chan, Akira Shizuo, Alain Vicari, Christine A. Biron, Giorgio Trinchieri, Francine Brière
Discussion(0)
No comments yet. Be the first to comment.